Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
RZ-001
DRUG
2 trials
Sponsors
Rznomics, Inc.
Conditions
Glioblastoma
Phase 1
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
Recruiting
NCT06102525
Rznomics, Inc.
Glioblastoma
Start: 2024-10-08
End: 2029-05-31
Target: 43
Updated: 2025-09-05
Unknown Phase
Expanded Access Program for GBM Subjects
NCT06676891
Rznomics, Inc.
Glioblastoma
Updated: 2025-01-08